New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Pharmacologic restraint used in 3 percent of pediatric mental health admissions

Pharmacologic restraint used in 3 percent of pediatric mental health admissions

by Elana GotkineThe use of pharmacologic restraints occurs in 3 percent of hospitalizations for children admitted with a primary mental health diagnosis, according to a study published online Dec. 11
Breakthroughs January 26,2024
Pharmacologic restraint used in 3 percent of pediatric mental health admissions

Pharmacologic restraint used in 3 percent of pediatric mental health admissions

by Elana GotkineThe use of pharmacologic restraints occurs in 3 percent of hospitalizations for children admitted with a primary mental health diagnosis, according to a study published online Dec. 11
Breakthroughs January 26,2024
Drug-drug interactions seen in 21.4% of children with medication exposure

Drug-drug interactions seen in 21.4% of children with medication exposure

by Elana GotkineMore than 20% of children with two or more medication exposures experience major drug-drug interactions (DDIs) annually, according to a study published online Jan. 4 inPediatrics
Breakthroughs January 26,2024
Drug-drug interactions seen in 21.4% of children with medication exposure

Drug-drug interactions seen in 21.4% of children with medication exposure

by Elana GotkineMore than 20% of children with two or more medication exposures experience major drug-drug interactions (DDIs) annually, according to a study published online Jan. 4 inPediatrics
Breakthroughs January 26,2024
Cell therapy appears safe and effective for lymphoma in remission

Cell therapy appears safe and effective for lymphoma in remission

byUniversity of Miami Leonard M. Miller School of MedicineCredit: University of Miami Leonard M. Miller School of MedicineA study led by researchers at Sylvester Comprehensive Cancer Center at t
Oncology January 26,2024
Cell therapy appears safe and effective for lymphoma in remission

Cell therapy appears safe and effective for lymphoma in remission

byUniversity of Miami Leonard M. Miller School of MedicineCredit: University of Miami Leonard M. Miller School of MedicineA study led by researchers at Sylvester Comprehensive Cancer Center at t
Oncology January 26,2024
Patients regain much weight after stopping new obesity drug: Study

Patients regain much weight after stopping new obesity drug: Study

This is an image of a weight scale. Credit: CDC/Debora CartagenaA new generation of obesity drugs often delivers dramatic weight loss, but many patients wonder what happens when they stop treatment.On
Breakthroughs January 26,2024
Patients regain much weight after stopping new obesity drug: Study

Patients regain much weight after stopping new obesity drug: Study

This is an image of a weight scale. Credit: CDC/Debora CartagenaA new generation of obesity drugs often delivers dramatic weight loss, but many patients wonder what happens when they stop treatment.On
Breakthroughs January 26,2024
COVID-19: The persistence of SARS-CoV-2 in the lungs and the role of innate immunity

COVID-19: The persistence of SARS-CoV-2 in the lungs and the role of innate immunity

byPasteur InstituteThe study showed that the SARS-CoV-2 virus is transmitted from one macrophage to another via bridge-like cellular projections, enabling it to spread. The cell nucleus is highl
Public Health & Prevention January 26,2024
COVID-19: The persistence of SARS-CoV-2 in the lungs and the role of innate immunity

COVID-19: The persistence of SARS-CoV-2 in the lungs and the role of innate immunity

byPasteur InstituteThe study showed that the SARS-CoV-2 virus is transmitted from one macrophage to another via bridge-like cellular projections, enabling it to spread. The cell nucleus is highl
Public Health & Prevention January 26,2024
Dapagliflozin cuts cardiovascular events in patients with heart failure, T2D

Dapagliflozin cuts cardiovascular events in patients with heart failure, T2D

by Elana GotkineFor patients with heart failure and type 2 diabetes (T2D), dapagliflozin does not reduce urinary albumin-to-creatinine ratio (UACR) but does reduce some cardiovascular events, accordin
Breakthroughs January 26,2024
Dapagliflozin cuts cardiovascular events in patients with heart failure, T2D

Dapagliflozin cuts cardiovascular events in patients with heart failure, T2D

by Elana GotkineFor patients with heart failure and type 2 diabetes (T2D), dapagliflozin does not reduce urinary albumin-to-creatinine ratio (UACR) but does reduce some cardiovascular events, accordin
Breakthroughs January 26,2024
Researchers discover deep structural biology connections that help improve CAR therapy

Researchers discover deep structural biology connections that help improve CAR therapy

byChildren's Hospital of PhiladelphiaCredit: Nikolaos SgourakisChimeric antigen receptors (CARs) have opened up an exciting new field of therapeutic advancements for rare and difficult-to-tr
Oncology January 26,2024
Researchers discover deep structural biology connections that help improve CAR therapy

Researchers discover deep structural biology connections that help improve CAR therapy

byChildren's Hospital of PhiladelphiaCredit: Nikolaos SgourakisChimeric antigen receptors (CARs) have opened up an exciting new field of therapeutic advancements for rare and difficult-to-tr
Oncology January 26,2024
Pathogens use force to breach immune defenses, study finds

Pathogens use force to breach immune defenses, study finds

by Kevin Fryling,Indiana UniversityCredit: Pixabay/CC0 Public DomainSimilar to a burglar breaking a window to get into a house, Indiana University researchers have discovered a previously unknow
Public Health & Prevention January 26,2024
Pathogens use force to breach immune defenses, study finds

Pathogens use force to breach immune defenses, study finds

by Kevin Fryling,Indiana UniversityCredit: Pixabay/CC0 Public DomainSimilar to a burglar breaking a window to get into a house, Indiana University researchers have discovered a previously unknow
Public Health & Prevention January 26,2024
Poison center calls related to injected weight-loss drugs up 1,500%

Poison center calls related to injected weight-loss drugs up 1,500%

by Nancy Clanton, The Atlanta Journal-ConstitutionCredit: Pixabay/CC0 Public DomainAmerica's Poison Centers reported nearly 3,000 calls this year involving the weight loss drug semaglutide—a 15-fo
Breakthroughs January 26,2024
Poison center calls related to injected weight-loss drugs up 1,500%

Poison center calls related to injected weight-loss drugs up 1,500%

by Nancy Clanton, The Atlanta Journal-ConstitutionCredit: Pixabay/CC0 Public DomainAmerica's Poison Centers reported nearly 3,000 calls this year involving the weight loss drug semaglutide—a 15-fo
Breakthroughs January 26,2024
Researchers reveal uncharted liver-focused pathway in gene therapy immune responses

Researchers reveal uncharted liver-focused pathway in gene therapy immune responses

byIndiana University School of MedicineGraphical Abstract. Credit:Molecular Therapy(2023). DOI: 10.1016/j.ymthe.2023.11.029Indiana University School of Medicine researchers have unco
Hepatobiliary&Pancreas Surgery January 26,2024
Researchers reveal uncharted liver-focused pathway in gene therapy immune responses

Researchers reveal uncharted liver-focused pathway in gene therapy immune responses

byIndiana University School of MedicineGraphical Abstract. Credit:Molecular Therapy(2023). DOI: 10.1016/j.ymthe.2023.11.029Indiana University School of Medicine researchers have unco
Hepatobiliary&Pancreas Surgery January 26,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com